Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Protoc. 2012 Dec;7(12):2180-92. doi: 10.1038/nprot.2012.138. Epub 2012 Nov 29.

Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccines.

Author information

1
Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA.

Abstract

Here we describe how to isolate carbohydrate-specific T cell clones (for which we propose the designation 'Tcarbs') after stimulation by two glycoconjugate vaccines. We describe how to prepare, purify and characterize two model glycoconjugate vaccines that can be used to generate Tcarbs. These glycoconjugate vaccines (GBSIII-OVA and GBSIII-TT) are synthesized by conjugation of type III group B streptococcal polysaccharide (GBSIII) to ovalbumin (OVA) or tetanus toxoid (TT). Upon immunization of mice with GBSIII-OVA, carbohydrate epitopes are presented to and recognized by CD4(+) T cells. Subsequently, polysaccharide-recognizing CD4(+) T cells are expanded in vitro by stimulating splenic CD4(+) T cells with GBSIII-TT. The sequential use of two distinct glycoconjugate vaccines containing the same polysaccharide conjugated to heterologous carrier proteins selects for and expands carbohydrate-specific T cells. This protocol can readily be adapted to study the stimulation of the immune system by alternative glycoconjugate vaccines. This protocol takes 1-2 years to complete.

PMID:
23196974
PMCID:
PMC4133772
DOI:
10.1038/nprot.2012.138
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center